{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:17:30Z","timestamp":1791029850486,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.iac.2012.06.012","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T20:06:10Z","timestamp":1344456370000},"page":"433-445","source":"Crossref","is-referenced-by-count":19,"title":["Urinary leukotriene E4 as a Biomarker of Exposure, Susceptibility and Risk in Asthma"],"prefix":"10.1016","volume":"32","author":[{"given":"Nathan","family":"Rabinovitch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2012.06.012_bib1","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1378\/chest.127.4.1312","article-title":"Cysteinyl leukotrienes in allergic inflammation: strategic target for therapy","volume":"127","author":"Busse","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.iac.2012.06.012_bib2","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/21658","article-title":"Characterization of the human cysteinyl leukotriene CysLT1 receptor","volume":"399","author":"Lynch","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.iac.2012.06.012_bib3","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1046\/j.1472-9725.2001.00026.x","article-title":"Cloning and expression of leukotriene receptors","volume":"1","author":"Evans","year":"2001","journal-title":"Clin Exp Allerg Rev"},{"key":"10.1016\/j.iac.2012.06.012_bib4","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1164\/ajrccm.163.1.2003101","article-title":"Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes","volume":"163","author":"Figueroa","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib5","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1073\/pnas.141221498","article-title":"Cysteinyl leukotriene receptor 1 is also a pyrimidinergic receptor and is expressed by human mast cells","volume":"98","author":"Mellor","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.iac.2012.06.012_bib6","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.4049\/jimmunol.178.8.5262","article-title":"IFN-gamma induces cysteinyl leukotriene receptor 2 expression and enhances the responsiveness of human endothelial cells to cysteinyl leukotrienes","volume":"178","author":"Woszczek","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0022-3565(24)36665-0","article-title":"Cysteinyl leukotrienes induce P-selectin expression in human endothelial cells via a non-CysLT1 receptor-mediated mechanism","volume":"281","author":"Pedersen","year":"1997","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.iac.2012.06.012_bib8","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1161\/01.CIR.92.11.3304","article-title":"Peptido-leukotrienes are potent agonists of von Willebrand factor secretion and P-selectin surface expression in human umbilical vein endothelial cells","volume":"92","author":"Datta","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.iac.2012.06.012_bib9","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1161\/01.CIR.0000147775.50954.AA","article-title":"Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure","volume":"110","author":"Hui","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.iac.2012.06.012_bib10","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1084\/jem.20091240","article-title":"Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor","volume":"206","author":"Paruchuri","year":"2009","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2012.06.012_bib11","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1159\/000234628","article-title":"Relationship between leukotriene C4 and uteroglobulin-like protein in nasal and tracheobronchial mucosa of children. Implication in acute respiratory illnesses","volume":"86","author":"Volovitz","year":"1988","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib12","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0090-6980(87)90035-9","article-title":"Critical consideration in the development of an assay for sulfidopeptide leukotrienes in plasma","volume":"33","author":"Heavey","year":"1987","journal-title":"Prostaglandins"},{"key":"10.1016\/j.iac.2012.06.012_bib13","first-page":"75","article-title":"Comparison of urinary leukotriene E4 and 16-carboxyetranordihydroleukotriene E4 excretion in allergic asthmatics after inhaled allergen","volume":"3","author":"Tagari","year":"1990","journal-title":"Eicosanoids"},{"key":"10.1016\/j.iac.2012.06.012_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/ajrccm\/146.1.96","article-title":"Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocation with allergen, aspirin, leukotriene D4 and histamine in asthmatics","volume":"146","author":"Kumlin","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2012.06.012_bib15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1432-1033.1990.tb19458.x","article-title":"Metabolism of cysteinyl leukotrienes in monkey and man","volume":"194","author":"Huber","year":"1990","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.iac.2012.06.012_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1365-2222.1995.tb01079.x","article-title":"Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans","volume":"25","author":"Kumlin","year":"1995","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.iac.2012.06.012_bib17","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1164\/ajrccm.161.supplement_1.ltta-20","article-title":"Measurement of leukotrienes in humans","volume":"161","author":"Kumlin","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0090-6980(98)00027-6","article-title":"Immunoaffinity resin for purification of urinary leukotriene E4","volume":"55","author":"Westcott","year":"1998","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"877","key":"10.1016\/j.iac.2012.06.012_bib19","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.jchromb.2009.08.011","article-title":"Leukotriene-E4 in human urine: comparison of on-line purification and liquid chromatography-tandem mass spectrometry to affinity purification followed by enzyme immunoassay","volume":"1","author":"Armstrong","year":"2009","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.iac.2012.06.012_bib20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.2116\/analsci.17.709","article-title":"Direct injection method for quantitation of endogenous leukotriene E4 in human urine by liquid chromatography\/electrospray ionization tandem mass spectrometry with a column-switching technique","volume":"17","author":"Kishi","year":"2001","journal-title":"Anal Sci"},{"key":"10.1016\/j.iac.2012.06.012_bib21","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1111\/j.1365-2222.2004.1912.x","article-title":"Urinary leukotriene E4 and 9a, 11b-prostaglandin F2 concentrations in mild, moderate and severe asthma, and in healthy subjects","volume":"34","author":"Misso","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2012.06.012_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1398-9995.2006.00979.x","article-title":"ALOX5 promoter genotype, asthma severity and LTC production by eosinophils","volume":"61","author":"Kalayci","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2012.06.012_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.plefa.2009.05.022","article-title":"Leukotriene pathway polymorphisms are associated with altered cysteinyl leukotriene production in children with acute asthma","volume":"81","author":"Bizzintino","year":"2009","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.iac.2012.06.012_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1684\/ejd.2011.1163","article-title":"Polymorphisms of cyclo-oxygenases and 5-lipo-oxygenase-activating protein are associated with chronic spontaneous urticaria and urinary leukotriene E4","volume":"21","author":"Di Lorenzo","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.iac.2012.06.012_bib25","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.85.1.230","article-title":"Increased urinary leukotriene excretion in patients with cardiac ischemia. In\u00a0vivo evidence for 5-lipoxygenase activation","volume":"85","author":"Carry","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.iac.2012.06.012_bib26","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.293.18.2245","article-title":"Effects of a 5-lipoxygenase-activating protein inhibitor on biomarkers associated with risk of myocardial infarction: a randomized trial","volume":"293","author":"Hakonarson","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.iac.2012.06.012_bib27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/00019501-199310000-00009","article-title":"Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery","volume":"4","author":"Allen","year":"1993","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.iac.2012.06.012_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1046\/j.1365-2133.2001.03947.x","article-title":"Increased urinary leukotriene E4 excretion in patients with atopic dermatitis","volume":"144","author":"Hishinuma","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.iac.2012.06.012_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1054\/plef.2001.0329","article-title":"Difference in urinary 11-dehydro TXB2 and LTE4 excretion in patients with rheumatoid arthritis","volume":"65","author":"Nakamura","year":"2001","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.iac.2012.06.012_bib30","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00005176-199505000-00005","article-title":"Levels of peptidoleukotriene E4 are elevated in active Crohn's disease","volume":"20","author":"Kim","year":"1995","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.iac.2012.06.012_bib31","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1111\/j.1471-4159.1990.tb04915.x","article-title":"Identification and characterization of cysteinyl-leukotriene formation in tissue slices from human intracranial tumors: evidence for their biosynthesis under in\u00a0vivo conditions","volume":"54","author":"Simmet","year":"1990","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.iac.2012.06.012_bib32","doi-asserted-by":"crossref","first-page":"E37","DOI":"10.1161\/01.ATV.0000082689.46538.DF","article-title":"Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells","volume":"23","author":"Sjostrom","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.iac.2012.06.012_bib33","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/thx.2005.041913","article-title":"Relation between bronchial responsiveness to inhaled leukotriene D4 and markers of leukotriene biosynthesis","volume":"60","author":"Gyllfors","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.iac.2012.06.012_bib34","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0092-8674(00)00179-3","article-title":"The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3beta, ELC)-dependent mobilization of dendritic cells to lymph nodes","volume":"103","author":"Robbiani","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.iac.2012.06.012_bib35","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1067\/mai.2002.125000","article-title":"The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects","volume":"110","author":"Braccioni","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib36","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.RES.77.5.879","article-title":"Leukotriene C4\/D4 induces P-selectin and sialyl Lewis (x)-dependent alterations in leukocyte kinetics in\u00a0vivo","volume":"77","author":"Kanwar","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/j.iac.2012.06.012_bib37","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1164\/ajrccm.161.6.9907054","article-title":"Leukotriene receptor antagonists and synthesis inhibitors reverse survival in eosinophils of asthmatic individuals","volume":"161","author":"Lee","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib38","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1084\/jem.20020044","article-title":"Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists","volume":"195","author":"Mellor","year":"2002","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.iac.2012.06.012_bib39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jaci.2004.10.021","article-title":"Leukotriene E (4)-induced persistent eosinophilia and airway obstruction are reversed by zafirlukast in patients with asthma","volume":"115","author":"Laitinen","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2222.1986.tb01960.x","article-title":"Effect of leukotriene D4 on nasal mucosal blood\u00a0flow, nasal airway resistance and nasal secretion in humans","volume":"16","author":"Bisgaard","year":"1986","journal-title":"Clin Allergy"},{"key":"10.1016\/j.iac.2012.06.012_bib41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0165-6147(00)89059-8","article-title":"Cysteinyl leukotrienes in asthma: old mediators up to new tricks","volume":"16","author":"Hay","year":"1995","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.iac.2012.06.012_bib42","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1067\/mai.2003.1451","article-title":"CysLT1 receptor upregulation by TGF-beta and IL-13 is associated with bronchial smooth muscle cell proliferation in response to LTD4","volume":"111","author":"Espinosa","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib43","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1164\/rccm.200501-088OC","article-title":"Reversal of allergen-induced airway remodeling by CysLT1 receptor blockade","volume":"173","author":"Henderson","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib44","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1164\/ajrccm\/144.6.1411","article-title":"Urinary leukotriene E4 levels after allergen and exercise challenge in bronchial asthma","volume":"144","author":"Smith","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2012.06.012_bib45","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1164\/rccm.200412-1667OC","article-title":"Inflammatory basis of exercise-induced bronchoconstriction","volume":"172","author":"Hallstrand","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib46","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1164\/rccm.201010-1706OC","article-title":"The response of children with asthma to ambient particulate is modified by tobacco smoke exposure","volume":"184","author":"Rabinovitch","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib47","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1164\/rccm.200509-1393OC","article-title":"Particulate levels are associated with early asthma worsening in children with persistent disease","volume":"173","author":"Rabinovitch","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib48","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ppul.20285","article-title":"Leukotriene synthesis during respiratory syncytial virus bronchiolitis: influence of age and atopy","volume":"40","author":"Piedimonte","year":"2005","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.iac.2012.06.012_bib49","first-page":"1132","article-title":"Clinical evaluation of urinary leukotriene e4 levels in children with respiratory syncytial virus infection","volume":"52","author":"Takahashi","year":"2003","journal-title":"Arerugi"},{"key":"10.1016\/j.iac.2012.06.012_bib50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200407-894OC","article-title":"Montelukast reduces asthma exacerbations in 2 to 5 year-old children with intermittent asthma","volume":"171","author":"Bisgaard","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib51","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2362.2010.02297.x","article-title":"Beclomethasone dipropionate blunts allergen-induced early increase in urinary LTE4","volume":"6","author":"Bartoli","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.iac.2012.06.012_bib52","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1034\/j.1399-3003.2000.16d03.x","article-title":"Urinary excretion of leukotriene E4 and eosinophil protein X in children with atopic asthma","volume":"16","author":"Severien","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2012.06.012_bib53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jaci.2004.06.054","article-title":"Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children","volume":"114","author":"Mondino","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib54","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1164\/rccm.200206-509OC","article-title":"Effects of montelukast and budesonide on airway responses and airway inflammation in asthma","volume":"166","author":"Leigh","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib55","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.7326\/0003-4819-119-11-199312010-00001","article-title":"The effect of inhibition of 5-lipoxygenase by zileuton in mild-to-moderate asthma","volume":"119","author":"Israel","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.iac.2012.06.012_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1164\/ajrccm.165.1.2010080","article-title":"Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial","volume":"165","author":"Dahlen","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib57","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1111\/j.1365-2222.2004.02041.x","article-title":"Effect of montelukast compared with inhaled fluticasone on airway inflammation","volume":"34","author":"Overbeek","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2012.06.012_bib58","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0091-6749(95)70263-6","article-title":"Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma","volume":"96","author":"Asano","year":"1995","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib59","first-page":"1106","volume":"45","author":"Yamamoto","year":"1996","journal-title":"Arerugi"},{"key":"10.1016\/j.iac.2012.06.012_bib60","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0090-6980(00)00091-5","article-title":"Difference in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients","volume":"62","author":"Suzuki","year":"2000","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.iac.2012.06.012_bib61","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1183\/09031936.93.05060693","article-title":"Urinary leukotriene E4 in bronchial asthma","volume":"5","author":"Smith","year":"1992","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2012.06.012_bib62","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1164\/ajrccm\/143.5_Pt_1.1025","article-title":"Urinary LTE4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects","volume":"143","author":"Christie","year":"1991","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2012.06.012_bib63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1398-9995.1997.tb01032.x","article-title":"Urinary leukotriene E4 and 11-dehydro-thromboxane B2 in patients with aspirin-sensitive asthma","volume":"52","author":"Oosaki","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2012.06.012_bib64","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.jaci.2003.10.068","article-title":"Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): involvement of chronic hyperplastic rhinosinusitis with nasal polyposis","volume":"113","author":"Higashi","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib65","first-page":"20","article-title":"Aspirin induced asthma (AIA) with nasal polyps has the highest basal LTE4 excretion: a study vs AIA without polyps, mild atopic asthma, and normal controls","volume":"38","author":"Micheletto","year":"2006","journal-title":"Allerg Immunol (Paris)"},{"key":"10.1016\/j.iac.2012.06.012_bib66","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0954-6111(03)00253-1","article-title":"High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma","volume":"97","author":"Vachier","year":"2003","journal-title":"Respir Med"},{"key":"10.1016\/j.iac.2012.06.012_bib67","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1378\/chest.120.6.1822","article-title":"Circadian characteristics of urinary leukotriene E(4) in healthy subjects and nocturnal asthmatic patients","volume":"120","author":"Kurokawa","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.iac.2012.06.012_bib68","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0091-6749(96)80149-7","article-title":"Urinary leukotriene E4 in the assessment of nocturnal asthma","volume":"97","author":"Bellia","year":"1996","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib69","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jaci.2006.05.011","article-title":"Urine leukotriene E4 levels are associated with decreased pulmonary function in children with persistent airway obstruction","volume":"118","author":"Rabinovitch","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib70","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2008.03.016","article-title":"Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast","volume":"121","author":"Rabinovitch","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib71","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/thorax.2003.006825","article-title":"Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation","volume":"59","author":"Green","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.iac.2012.06.012_bib72","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1159\/000237697","article-title":"Urinary excretion of leukotriene E4 and 11-dehydrothromboxane B2 in patients with spontaneous asthma attacks","volume":"114","author":"Oosaki","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib73","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jaci.2011.05.035","article-title":"Urinary leukotriene E4 levels identify children with tobacco smoke exposure at risk for asthma exacerbation","volume":"128","author":"Rabinovitch","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib74","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.200511-1746OC","article-title":"Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma","volume":"175","author":"Lazarus","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.iac.2012.06.012_bib75","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2004.11.014","article-title":"Characterization of within-subject responses to fluticasone and montelukast in childhood asthma","volume":"115","author":"Szefler","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaci.2005.10.012","article-title":"Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma","volume":"117","author":"Zeiger","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2012.06.012_bib77","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00408-006-0001-8","article-title":"Relationship between urinary cysteinyl leukotriene E4 levels and clinical response to antileukotriene treatment in patients with asthma","volume":"185","author":"Cai","year":"2007","journal-title":"Lung"},{"key":"10.1016\/j.iac.2012.06.012_bib78","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jaci.2010.07.008","article-title":"Urinary leukotriene E4\/exhaled nitric oxide ratio and montelukast response in childhood asthma","volume":"126","author":"Rabinovitch","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856112000628?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856112000628?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T18:16:52Z","timestamp":1743963412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856112000628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S0889856112000628"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2012.06.012","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}